Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.58 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CTSK | P43235 | 1/20 | 0.47 |
| ▸ | METTL3 | Q86U44 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MC4R | P32245 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | MC3R | P41968 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL940788 | 1.00 | HSP90AA1 (0.58) | HSP90AA1BAZ2BGAACTSKMETTL3 | |
| SCHEMBL9876224 | 0.79 | GAA (0.60) | HSP90AA1GAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9876221 | 0.79 | GAA (0.60) | HSP90AA1GAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL28402900 | 0.78 | HSP90AA1 (0.67) | HSP90AA1BAZ2BGAANPC1RAB9A | |
| SCHEMBL941092 | 0.77 | TOP2A (0.70) | HSP90AA1CTSKMETTL3ATMRAB9A | |
| SCHEMBL941093 | 0.77 | TOP2A (0.70) | HSP90AA1CTSKMETTL3ATMRAB9A | |
| SCHEMBL9319994 | 0.77 | TOP2A (0.70) | HSP90AA1CTSKMETTL3ATMRAB9A | |
| SCHEMBL17975316 | 0.77 | HSP90AA1 (0.71) | HSP90AA1BAZ2BGAANPC1RAB9A | |
| Hydrochloric Acid SCHEMBL28396822 | 0.77 | HSP90AA1 (0.65) | HSP90AA1BAZ2BGAANPC1RAB9A | |
| SCHEMBL28493225 | 0.76 | TOP2A (0.68) | HSP90AA1CTSKMETTL3ATMRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111116495-B | Inorganic and organic hybrid Keggin type polyoxometallate compound, preparation method thereof and application thereof in antibiosis | 河南大学 | 2022-07-22 | — | — | CN | claimed |
| CN-111138372-A | Preparation and application of acetylpyrazine thiosemicarbazone metal chelating agent and metal complex thereof | 平顶山学院 | 2020-05-12 | — | — | CN | claimed |
| CN-111116495-A | Inorganic-organic hybrid Keggin type polyoxometallate compound, preparation method thereof and application thereof in antibiosis | 河南大学 | 2020-05-08 | — | — | CN | claimed |
| CN-110201640-A | HPAs complex, the nano complexes material containing it and the application in terms of adsorbing dyestuff | 河南大学 | 2019-09-06 | — | — | CN | claimed |
| US-20250177456-A1 | METHOD AND COMPOSITION FOR PREVENTING AND/OR TREATING METABOLIC DISORDERS | UNIV SHANDONG (CN) | 2025-06-05 | — | — | US | disclosed |
| CN-111116495-B | Inorganic and organic hybrid Keggin type polyoxometallate compound, preparation method thereof and application thereof in antibiosis | 河南大学 | 2022-07-22 | — | — | CN | disclosed |
| CN-111116495-B | Inorganic and organic hybrid Keggin type polyoxometallate compound, preparation method thereof and application thereof in antibiosis | 河南大学 | 2022-07-22 | — | — | CN | disclosed |
| CN-111138372-A | Preparation and application of acetylpyrazine thiosemicarbazone metal chelating agent and metal complex thereof | 平顶山学院 | 2020-05-12 | — | — | CN | disclosed |
| CN-111138372-A | Preparation and application of acetylpyrazine thiosemicarbazone metal chelating agent and metal complex thereof | 平顶山学院 | 2020-05-12 | — | — | CN | disclosed |
| CN-111138372-A | Preparation and application of acetylpyrazine thiosemicarbazone metal chelating agent and metal complex thereof | 平顶山学院 | 2020-05-12 | — | — | CN | disclosed |
| CN-111116495-A | Inorganic-organic hybrid Keggin type polyoxometallate compound, preparation method thereof and application thereof in antibiosis | 河南大学 | 2020-05-08 | — | — | CN | disclosed |
| CN-111116495-A | Inorganic-organic hybrid Keggin type polyoxometallate compound, preparation method thereof and application thereof in antibiosis | 河南大学 | 2020-05-08 | — | — | CN | disclosed |
| US-7425636-B2 | Thiadiazoline derivative | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-09-16 | — | — | US | disclosed |
| US-20080207706-A1 | THIADIAZOLINE DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD (JP) | 2008-08-28 | — | — | US | disclosed |
| EP-1847534-A2 | Thiadiazoline derivative | Kyowa Hakko Kogyo Co., Ltd (JP) | 2007-10-24 | — | — | EP | disclosed |
| US-20070213380-A1 | Thiadiazoline derivative | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-09-13 | — | — | US | disclosed |
| US-20070155804-A1 | Mitotic kinesin inhibitor | KYOWA HAKKO KOGYO CO., LTD. OF TOKYO, JAPAN FUJI PHOTO FILM CO., LTD. KANAGAWA, JAPAN | 2007-07-05 | — | — | US | disclosed |
| US-20060074113-A1 | Thiadiazoline derivative | KYOWA KIRIN CO., LTD. (JP) | 2006-04-06 | — | — | US | disclosed |
| EP-1616866-A1 | M-STAGE KINESIN INHIBITOR | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2006-01-18 | — | — | EP | disclosed |
| EP-1454903-A1 | THIADIAZOLINE DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074113-A1 | Thiadiazoline derivative | BRWD1, RB1, ARG2 | HSP90AA1 288/4885BAZ2B 124/4885GAA 4130/4885 |
| US-20070155804-A1 | Mitotic kinesin inhibitor | KIF15, KIF5A, KIF5B | HSP90AA1 1114/4885BAZ2B 886/4885GAA 1882/4885 |
| US-20250177456-A1 | METHOD AND COMPOSITION FOR PREVENTING AND/OR TREATING METABOLIC DISORDERS | LIPC, GYS2, PNLIP | HSP90AA1 2786/4885BAZ2B 4647/4885GAA 159/4885 |
| US-20070213380-A1 | Thiadiazoline derivative | BRWD1, RB1, ARG2 | HSP90AA1 288/4885BAZ2B 124/4885GAA 4130/4885 |
| US-20080207706-A1 | THIADIAZOLINE DERIVATIVE | BRWD1, RB1, ARG2 | HSP90AA1 288/4885BAZ2B 124/4885GAA 4130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.